Voyageur Minerals Ltd.

• Voyageur Pharmaceuticals, Upgrades Frances Creek Barite to 98% BaSO4 with First Stage Gravity Separation

  Voyageur Pharmaceuticals Ltd. has been working with SGS Canada to advance the Frances Creek high purity barium sulfate project. SGS Canada is currently working with the Frances Creek barite mineralized breccia and has successfully gravity separated a concentrated grade of 98.6% barium sulfate. The samples have been sent to the pharmacy group at SGS for further testing and the results will be available in January. The [...]

  weiterlesen

  18.12.2019

  von The Newswire
• Voyageur Minerals Ltd. Change of Name to Voyageur Pharmaceuticals Ltd.

  Voyageur Minerals Ltd. is pleased to announce the following matters: Change of Name The Company is pleased to announce that shareholders of the Company approved a change of the Company's name to Voyageur Pharmaceuticals Ltd. Commenting on the name change, CEO Brent Willis stated that "this name change reflects our focus on providing "earth to bottle" pharmaceutical products for medical applications, primarily for [...]

  weiterlesen

  10.12.2019

  von The Newswire
• Voyageur Closes Second Tranche of Non-Brokered Private Placement, Announces Private Placement Extension and Resignation of Director

  Voyageur Minerals Ltd. is pleased to report that it recently closed the second tranche of its previously announced private placement, receiving aggregate gross proceeds of $100,637.48 from the issuance and sale of 1,341,833 units at a price of $0.075 per Unit. Each Unit consists of one common share and one common share purchase warrant entitling the holder thereof to purchase one common share at an exercise price of [...]

  weiterlesen

  05.12.2019

  von GlobeNewswire
• Voyageur Minerals retains Frontier Merchant Capital Group for marketing and financial communication services

  Voyageur Minerals Ltd. is pleased to announce that it has retained the services of Frontier Merchant Capital Group to provide marketing and financial communications services. FronTier is an investor relations and marketing group with a home office in Toronto, Canada. FronTier will assist the company by increasing market awareness for the company using a number of financial market communications initiatives, including [...]

  weiterlesen

  07.11.2019

  von GlobeNewswire
• Voyageur Minerals’ Joint Venture Company, ImagingX Pharmaceuticals, Submits Third Barium Contrast Product to Health Canada for Registration

  Voyageur Minerals Ltd. is pleased to announce the formulation and registration submission to Health Canada for its new drug product, MultiXBa. ImagingX Pharmaceuticals Ltd , a Voyageur joint-venture company described below, has submitted a total of three products for registration to Health Canada, with two more products anticipated to follow in the near term. MultiXBa is a specially formulated low density dry Barium [...]

  weiterlesen

  05.11.2019

  von GlobeNewswire

weitere engl. Meldungen